SCHEMBL515404

SCHEMBL515404

C=CCCCCCC(=O)OC(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.65
ALDH1A1 P00352 4/20 0.65
MAPT P10636 4/20 0.52
ABCC4 O15439 1/20 0.52
TSHR P16473 2/20 0.47
FAAH O00519 1/20 0.45
MGLL Q99685 1/20 0.45
USP2 O75604 2/20 0.44
CYP3A4 P08684 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RECQL P46063 1/20 0.44
MAPK1 P28482 1/20 0.41
GAA P10253 1/20 0.40
EPHX2 P34913 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCD Q05655 1/20 0.40
PRKCA P17252 1/20 0.40
HPGD P15428 1/20 0.40
PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3122706 1.00 LMNA (0.65) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL3112597 1.00 LMNA (0.65) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL8430088 1.00 LMNA (0.65) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL3117003 1.00 LMNA (0.65) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL515320 1.00 LMNA (0.65) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL514945 0.98 LMNA (0.61) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL515890 0.92 LMNA (0.55) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL2520759 0.86 LMNA (0.61) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL19571072 0.85 LMNA (0.66) LMNAALDH1A1MAPTTSHRFAAH
SCHEMBL10075911 0.85 LMNA (0.66) LMNAALDH1A1MAPTTSHRFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109942474-A A kind of neighbour's nitrine-hydrazine class compound and preparation method thereof 华中科技大学 2019-06-28 CN disclosed
EP-2415740-B1 METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND KURARAY CO (JP) 2013-12-25 EP disclosed
US-8609886-B2 Method for producing high purity terminal olefin compound KURARAY CO., LTD. (JP) 2013-12-17 US disclosed
EP-2415740-A1 METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND Kuraray Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120029229-A1 METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND KURARAY CO., LTD. (JP) 2012-02-02 US disclosed
EP-1734061-B1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS INC (JP) 2010-04-07 EP disclosed
US-7393907-B2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2008-07-01 US disclosed
EP-1734061-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS, INC. (JP) 2006-12-20 EP disclosed
US-20040122192-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. 2004-06-24 US disclosed
US-20020156207-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2002-10-24 US disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029229-A1 METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND ADH1A, ADH1C, OSBP LMNA 3696/4885ALDH1A1 233/4885MAPT 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.